Last update 20 May 2025

XH-S004

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
XH-S004
Target
DPP-1
Action
inhibitors
Mechanism
DPP-1 inhibitors(Cathepsin C inhibitors)
Therapeutic Areas
Respiratory Diseases
Active Indication
Non-cystic fibrosis bronchiectasisPulmonary Disease, Chronic Obstructive
Inactive Indication-
Originator Organization
Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
Active Organization
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with XH-S004
NCT06981091
/ Not yet recruitingPhase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06236841
/ Not yet recruitingPhase 1
A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Food Effects of XH-S004 Single and Multiple Ascending Doses in Healthy Volunteers
CTR20251293
/ Not yet recruitingPhase 2
评价XH-S004片在非囊性纤维化支气管扩张症患者中有效性和安全性的多中心、随机、双盲、安慰剂平行对照的Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of XH-S004 tablets in patients with non-cystic fibrosis bronchiectasis
100 Clinical Results associated with XH-S004
Login to view more data
100 Translational Medicine associated with XH-S004
Login to view more data
100 Patents (Medical) associated with XH-S004
Login to view more data
100 Deals associated with XH-S004
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-cystic fibrosis bronchiectasisPhase 2
China
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
16 May 2025
Pulmonary Disease, Chronic ObstructivePhase 1
China
Zhejiang Xinghao Pengbo Pharmaceutical Co., Ltd.
19 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free